glucaric acid has been researched along with Anemias, Iron-Deficiency in 183 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (3.83) | 18.7374 |
| 1990's | 10 (5.46) | 18.2507 |
| 2000's | 71 (38.80) | 29.6817 |
| 2010's | 92 (50.27) | 24.3611 |
| 2020's | 3 (1.64) | 2.80 |
| Authors | Studies |
|---|---|
| Walther, CP; Winkelmayer, WC; Yan, J | 1 |
| Butragueño-Laiseca, L; de la Mata Navazo, S; Sánchez Galindo, AC; Santiago Lozano, MJ | 1 |
| Bai, Z; Feng, R; Guo, X; Hong, C; Qi, X; Romeiro, FG; Xu, X; Zhang, D | 1 |
| Batycky, A; Bernard, K; Dahl, NV; Li, Z; Macdougall, IC; Strauss, WE | 1 |
| Bhavi, SB; Jaju, PB | 1 |
| Chow, E; Kaneva, K; Kelly, MJ; Rosenfield, CG | 1 |
| Pai, AB | 1 |
| Muduma, G; Pollock, RF | 1 |
| Borchard, G; Di Francesco, T; Philipp, E | 1 |
| Borchard, G; Di Francesco, T | 1 |
| Abergel, A; Aumaitre, O; Bagel, S; Boisgard, S; Delpeuch, A; Ruivard, M; Sautou, V | 1 |
| Cunha, GJL; Menezes Falcão, L; Rocha, BML | 1 |
| Burden, R; Horgan, G; Moore, B; Pedlar, CR; Pollock, N; Whyte, GP | 1 |
| Arao, T; Kurozumi, A; Mori, H; Okada, Y; Tanaka, Y; Torimoto, K; Yamamoto, S | 1 |
| Lynn, S; McDaniel, J | 1 |
| Biggar, P; Hahn, KM | 1 |
| Beck-da-Silva, L; Bocchi, E; Clausell, N; de Albuquerque, D; Montera, MW; Moura, LZ; Pereira-Barretto, AC; Piardi, D; Rassi, S; Rohde, LE; Soder, S; Vilas-Boas, F | 1 |
| Barot, BS; Mehta, DM; Parejiya, PB; Shah, GB; Shelat, PK | 1 |
| Amet, S; Deray, G; Janus, N; Launay-Vacher, V; Mahi, L; Rey, JB; Rouillon, L; Scotte, F; Zakin, L | 1 |
| Münch, HG; Potthoff, SA | 1 |
| Cervellin, G; Lippi, G; Sanchis-Gomar, F | 1 |
| Achermann, R; Giger, M | 1 |
| Beck-da-Silva, L; Clausell, N; Rohde, LE | 1 |
| Bregman, DB; Buerkert, J; Butcher, A; Goodnough, LT; Hamerski, D; Harrington, RA; Iftikhar, H; Koch, TA; Mangoo-Karim, R; Martin, ER; Martinez, CO; Morris, D; Newman, GE; Onken, JE; Qunibi, WY; Ross, DL; Singh, B; Smith, MT | 1 |
| Braunhofer, P; Brock, E; Schneider, H; Troxler, J | 1 |
| Akin, M; Atay, E; Erdogan, F; Karadeniz, C; Karakus, YT; Oztekin, O; Yilmaz, B | 1 |
| Cornelius, C; Goldenberg, H; Praschberger, M; Scheiber-Mojdehkar, B; Schitegg, M; Sturm, B | 1 |
| Coloma, JL; Esteve, J; Masoller, N; Palacio, M; Perelló, MF | 1 |
| Dellanna, F; Hertel, J; Li, Z; Macdougall, IC; McLaughlin, J; Strauss, WE | 1 |
| Hammami Ghorbel, H; Lacour, JP; Passeron, T | 1 |
| Allen, LF; Bernard, K; Hetzel, D; Li, Z; Strauss, W; Urboniene, A | 1 |
| Cava-Sumner, B; Domínguez-Ortega, J; Kindelan-Recarte, C; Montojo-Guillén, C; Nuñez-Acevedo, B; Rodríguez-Jiménez, B | 1 |
| Li, J; Mi, C; Shi, Q; Xing, A; Yang, J; Yao, Q | 1 |
| Beguin, Y; Jaspers, A | 1 |
| Di Gennaro, F; Rivas, C; Toblli, JE | 1 |
| Chatzimichael, A; Mantadakis, E; Tsouvala, E; Xanthopoulou, V | 1 |
| Leng, W; Li, J; Mi, C; Shi, Q; Wazir, R; Xing, A; Yang, J; Yao, Q | 1 |
| Ambühl, PM; Bhandari, S; Christensen, JH; Coyne, DW; Essaian, AM; Kalra, PA; Kothari, J; Macdougall, IC; Thomsen, LL | 1 |
| Agarwal, R; Kusek, JW; Pappas, MK | 1 |
| Fukumoto, S; Takashi, Y | 1 |
| Allison, SJ | 1 |
| Allen, VM; Nash, CM | 1 |
| Brookhart, MA; Ellis, AR; Freburger, JK; Kshirsagar, AV; Wang, L; Winkelmayer, WC | 1 |
| Drüeke, TB; Massy, ZA | 1 |
| Angmo, S; Mukhija, K; Sandhir, R; Singhal, K; Singhal, NK; Yadav, H; Yadav, K | 1 |
| Clavel, T; Fedorak, R; Haller, D; Lagkouvardos, I; Lee, T; Lucio, M; Michalke, B; Schmidt, A; Schmitt-Kopplin, P; Smirnov, K; Walker, A | 1 |
| Bhatla, N; Kachhawa, G; Kriplani, A; Mahey, R; Mogili, KD; Saxena, R | 1 |
| Han, YM; Im, JP; Jung, HC; Kim, BG; Kim, JS; Koh, SJ; Shin, CM; Yoon, H | 1 |
| Dorsch, MP; Hanigan, S; Kaminsky, BM; Koelling, TM; Pogue, KT | 1 |
| Fell, LH; Fliser, D; Heine, GH; Rotter, B; Seiler-Mußler, S; Sellier, AB; Sester, M; Winter, P; Zawada, AM | 1 |
| Cebrián, C; Deira, J; Fernández-Pereira, L; Gómez-Martino, JR; González-Sanchidrián, S; Jiménez, M; Marín, J; Polanco, S; Tabernero, J | 1 |
| Coyne, DW; Daloul, R; Pandey, R | 1 |
| Macdougall, IC | 1 |
| Danko, I; Weidkamp, M | 1 |
| Lopes, AI; Maltez, C; Valério de Azevedo, S | 1 |
| Berger, SP; Daha, MR; de Vlaam, TP; Franssen, CF; Gaillard, CA; Gaya da Costa, M; Hempel, JC; Poppelaars, F; Seelen, MA | 1 |
| Achebe, MM; Auerbach, M; Derman, R; Modiano, MR; Roman, E; Thomsen, LL | 1 |
| Kapelushnik, J; Levy, J; Moser, A; Pinsk, V; Yerushalmi, B | 1 |
| Kaplinsky, C | 1 |
| Anirban, G; Gupta, KL; Jha, V; Kohli, HS; Sakhuja, V | 1 |
| Bailey, G; Cropper, L; Mostafa, S; Pugh-Clarke, K; Tagboto, S; Turner, J | 1 |
| Collins, AJ; Foley, RN; Gilbertson, DT; Ibrahim, HN; Zhang, R | 1 |
| Abbadi, R; Haddad, A; Marji, A | 1 |
| Clark, SF | 1 |
| Bisbe, E; Campos, A; Díez-Lobo, AI; García-Erce, JA; Muñoz, M; Sebastianes, C | 1 |
| Bencaiova, G; von Mandach, U; Zimmermann, R | 1 |
| Chiu, DY; Fenwick, S; Kalra, PA; Kolakkat, S; Lamerton, E; Peebles, G; Sinha, S | 1 |
| Dejaco, C; Gasche, C; Kulnigg, S; Teischinger, L; Waldhör, T | 1 |
| Asma, S; Boga, C; Ozdogu, H | 1 |
| Li, H; Wang, SX | 1 |
| Durran, A; Edwards, TJ; Hosie, KB; Mellor, N; Noble, EJ | 1 |
| Bârsan, L; Mircescu, G; Stanciu, A; Stancu, S | 1 |
| Acheson, AG; Brookes, MJ; Iqbal, T; Simpson, JA; Tselepis, C | 1 |
| Pramesh, CS; Ranganathan, P | 1 |
| Yee, J | 1 |
| Bregman, DB; Butcher, A; Goodnough, LT; Harrington, RA; Koch, TA; Morris, D; Onken, JE; Szczech, LA; Wolf, M | 1 |
| Berman, L; Firoz, BF; Goldberg, LH; Kaye, V; Landau, J | 1 |
| Agarwal, SK; Dogra, M; Gupta, A; Khaira, A | 1 |
| Bhandari, S; Chinnappa, S | 1 |
| Dakshina Murty, KV; Naidu, MU; Neela, P; Ram, R; Swarnalatha, G | 1 |
| Froessler, B; Papendorf, D | 1 |
| Agarwal, R; Dahl, NV; Leehey, DJ; Olsen, SM | 1 |
| Bager, P; Dahlerup, JF | 1 |
| Breymann, C; Krafft, A | 1 |
| Fenwick, S; Peebles, G | 1 |
| Auerbach, M | 1 |
| Buchanan, GR; Crary, SE; Hall, K | 1 |
| Cheng, S; Coppol, E; Kaakeh, Y; Shelly, J; Shepler, B | 1 |
| Dansaert, A; Kadri, A; Lafuma, A; Leonard, E; Rottembourg, J | 1 |
| Bokemeyer, B; Chopey, IV; Evstatiev, R; Gasche, C; Gutzwiller, FS; Iqbal, T; Khalif, IL; Marteau, P; Riopel, L; Stein, J | 1 |
| Gisbert, JP; Gomollón, F | 1 |
| Burrows, DM; Corcoran, HF; Dotzauer, H; Goggin, MM; Gozum, SD; Janis, GC; Lundberg, RA; Nguyen, A; Tann, CM | 1 |
| Chow, KU; Dignass, A; Stein, J | 1 |
| Angerosa, M; Cao, G; Oliveri, L; Toblli, JE | 1 |
| Korejo, R; Nasir, A; Yasmin, H | 1 |
| Christoph, P; Pfenniger, A; Schuller, C; Surbek, D | 1 |
| Bhandari, S; Muñoz, M; Reinisch, W; Staun, M | 1 |
| Ghosh, P; Kaundal, A; Kochhar, PK | 1 |
| Ávalos-Pinto, R; de la Llana-Ducrós, R; Garrido-Martín, P; Jimenez-Sosa, A; Martínez-Sanz, R; Nassar-Mansur, MI; Rodríguez Fortunez, PM; Virgos-Aller, TM | 1 |
| Abel, GA; Hevelone, N; Mandell, E; Okam, MM; Ross, A; Wentz, R | 1 |
| Fukumoto, S; Mori, H; Okada, Y; Tanaka, Y; Yamamoto, S | 1 |
| Hutchings, A; Jeans, A; Macdougall, IC; Wilson, PD | 1 |
| Cocchiaro, C; Dekker, G; Froessler, B; Hodyl, N; Saadat-Gilani, K | 1 |
| Bockeria, LA; Bockeria, O; Donakanian, S; Sokolskaya, M | 1 |
| Goldstein, SL; Morris, D; Warady, BA | 1 |
| Choi, GY; Kim, JS; Lee, ES; Lee, IS; Lee, JJ; Park, BR | 1 |
| Akarsu, S; Demir, H; Oguzoncul, F; Selek, S | 1 |
| Kildahl-Andersen, O; Kildahl-Andersen, R; Moore, KL; Tjønnfjord, GE | 1 |
| Breymann, C; Huch, A; Huch, R; Perewusnyk, G | 1 |
| Froger, H; Gottrand, F; Guimber, D; Mention, K; Michaud, L; Neuville, S; Turck, D | 1 |
| Mushtaq, A; Wali, A | 1 |
| Chuang, CL; Huang, TP; Liu, RS; Tarng, DC; Wei, YH | 1 |
| Agarwal, R; Coyne, DW; Dahl, N; Folkert, VW; Michael, B; Myirski, P; Warnock, DG | 1 |
| Edwards, JH | 1 |
| Kosch, M; Schaefer, RM | 2 |
| DESHMUKH, PL | 1 |
| DEVOE, RW; MOSES, LE | 1 |
| GARRISON, FE; HOBSON, JB; ITOGA, T; JONES, OW; LASZLO, J | 1 |
| Borisov, AV; Borisova, EV; Fesiuk, AF; Lovchinskiĭ, EV; Mordik, AI | 1 |
| Colfer, M | 1 |
| Folkert, VW | 1 |
| BENSLEY, EH; CAMERON, DG; GRAYSTON, V; WOOD, P | 1 |
| STRAHM, A; WALTER, F | 1 |
| HOLLY, RG | 1 |
| ASSALI, NS; NICHOLSON, DB | 1 |
| Al-Saloum, MM; Charytan, C; Schwenk, MH; Spinowitz, BS | 1 |
| Rodgers, GM; Silverstein, SB | 1 |
| Blumenstein, I; Dignass, AU; Jahnel, J; Schröder, O; Schrott, M; Stein, J | 1 |
| Abe, R; Horiuchi, T; Ogi, M; Wakabayashi, M; Wakabayashi, T | 1 |
| Bozhinova, S; Ivanova, I; Lukanova, M | 1 |
| El-Agroudy, A; El-Husseini, A; Hassan, N; Khalil, A; Sabry, A; Salem, A; Sheashaa, H; Sobh, M | 1 |
| Maslovsky, I | 1 |
| Dargan, PI; Jones, AL; Lawes, M; Thomson, AH; Wood, DM | 1 |
| de Weerth, A; Dignass, AU; Herfarth, H; Junge, U; Mickisch, O; Reinshagen, M; Schreiber, S; Schröder, O; Schrott, M; Seidler, U; Stein, J | 1 |
| Laman, CA; Rodgers, GM; Silverstein, SB | 1 |
| Govan, AD; Scott, JM | 1 |
| Huang, X; Katz, SD; Zhang, Q; Zheng, H | 1 |
| Bhandal, N; Russell, R | 1 |
| Raja, R; Rizkala, AR; Sirken, G | 1 |
| Juncà, J | 1 |
| Breymann, C; Canclini, C; Geisser, P; Stahel, M; von Seefried, B | 1 |
| Beck-da-Silva, L; Bocchi, E; Clausell, N; de Albuquerque, D; Montera, MW; Moura, LZ; Pereira-Barretto, AC; Rassi, S; Rohde, LE; Vilas-Boas, F | 1 |
| Ranfaing, E | 1 |
| Baribeault, D; Rosenberg, CL; Sane, R | 1 |
| Huch, R; Krafft, A; Schaefer, RM | 1 |
| Binder, T; Dvorská, M; Feldmár, P; Záhumenský, J; Zmrhalová, B | 1 |
| Vikrant, S | 1 |
| Charytan, C; Reed, J; Yee, J | 1 |
| Cangiano, JL; Noble, S; Reed, J; Singh, H; Van Wyck, DB | 1 |
| Agarwal, R; Bishu, K | 1 |
| Zager, RA | 1 |
| Breymann, C | 1 |
| Grzegorzewska, AE | 1 |
| Grekas, DM; Makedou, A; Makedou, K; Malindretos, P; Raptis, V; Rudenco, I; Sarafidis, PA | 1 |
| Di Gennaro, F; Duarte, P; Lombraña, A; Toblli, JE | 1 |
| Francis, GS; Kanderian, A | 1 |
| Pauly, RA; Wall, GC | 1 |
| Abraham, K; Ahmed, MS; Irvine, T; Lim, R; Wong, CF | 1 |
| Auerbach, M; Goodnough, LT; Maniatis, A; Picard, D | 1 |
| Birgegård, G; Hedenus, M | 1 |
| Ageeva, TA; Shkurupiĭ, VA | 1 |
| Blum, M; Frank, N; Iaina, A; Kaplan, E; Levi, BA; Peer, G; Silverberg, DS; Steinbruch, S | 1 |
| Abbas, M; Abotalib, Z; al-Meshari, A; al-Momen, AK; al-Nuaim, L; Khashogji, T; Saddique, A | 1 |
| Bowen, WH; Miguel, JC; Pearson, SK | 1 |
| Cynke, E | 1 |
| Hörl, WH; Sunder-Plassmann, G | 1 |
| Andrade, S; Colaço, S; Oliveira, C; Ponce, P; Santos, JP; Silva, J; Ventura, H | 1 |
| Sato, K; Shiraki, M | 1 |
| Atherton, DJ; Cox, I; Hann, I | 1 |
| Dejaco, C; Fueger, GF; Gangl, A; Gasche, C; Lochs, H; Reinisch, W; Tillinger, W; Waldhoer, T | 1 |
| Bailie, GR; Johnson, CA; Mason, NA | 1 |
| Descombes, E; Fellay, G | 1 |
| Adhikarla, R; Cavallo, G; Charytan, C; Gagnon, S; Levin, N; Spinowitz, BS; Van Wyck, DB | 1 |
| Breymann, C; Huch, A; Huch, R; Krafft, A | 1 |
| Al-Saloum, M; Charytan, C; Gagnon, S; Hafeez, T; Levin, N; Van Wyck, DB | 1 |
| Breymann, C; Huch, A; Huch, R; Visca, E | 1 |
| Feichtenschlager, T; Gasche, C; Male, C; Mayer, A; Mittermaier, C; Petritsch, W; Waldhoer, T | 1 |
| Duffy, CI | 1 |
| Agullès, O; Bayoumeu, F; Laxenaire, MC; Vial, F; Zaccabri, A | 1 |
| Baka, NE; Bayoumeu, F; Laxenaire, MC; Legagneur, H; Monnier-Barbarino, P; Subiran-Buisset, C | 1 |
26 review(s) available for glucaric acid and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron; Nanoparticles; Therapeutic Equivalency; Treatment Outcome | 2017 |
Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions.
Topics: Acute Disease; Anemia, Iron-Deficiency; Chronic Disease; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Hospitalization; Humans; Quality of Life; Renal Insufficiency, Chronic | 2018 |
[Importance of the different i.v. iron generations for everyday medical practice].
Topics: Anemia, Iron-Deficiency; Disaccharides; Dose-Response Relationship, Drug; Drug Substitution; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Maltose; Structure-Activity Relationship; Treatment Outcome | 2013 |
[Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease].
Topics: Administration, Oral; Anaphylaxis; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Oxidative Stress; Renal Dialysis | 2013 |
Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Birth Weight; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Iron; Pregnancy; Pregnancy Complications, Hematologic; Randomized Controlled Trials as Topic; Treatment Outcome | 2015 |
Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas.
Topics: Anemia, Iron-Deficiency; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron Deficiencies | 2014 |
Intravenous Iron Sucrose versus Oral Iron in the Treatment of Pregnancy with Iron Deficiency Anaemia: A Systematic Review.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Iron Compounds; Pregnancy; Pregnancy Complications, Hematologic | 2015 |
[Bone and Nutrition. The relationship between iron and phosphate metabolism].
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Humans; Hypophosphatemia; Injections, Intravenous; Iron; Osteomalacia; Phosphates; Renal Insufficiency, Chronic; Rickets, Hypophosphatemic | 2015 |
The Use of Parenteral Iron Therapy for the Treatment of Postpartum Anemia.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Iron-Dextran Complex; Puerperal Disorders | 2015 |
Iron Treatment Strategies in Dialysis-Dependent CKD.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Renal Dialysis; Transferrin | 2016 |
Iron Treatment Strategies in Nondialysis CKD.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron Compounds; Maltose; Renal Insufficiency, Chronic; Severity of Illness Index; Transferrin | 2016 |
Iron deficiency anemia: diagnosis and management.
Topics: Anemia, Iron-Deficiency; Antimicrobial Cationic Peptides; Biomarkers; Endoscopy, Digestive System; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hepcidins; Humans; Infusions, Parenteral; Iron; Iron Chelating Agents | 2009 |
A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Clinical Trials as Topic; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Ferrous Compounds; Glucaric Acid; Humans; Iron-Dextran Complex; Renal Dialysis; Renal Insufficiency, Chronic | 2011 |
State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease.
Topics: Algorithms; Anemia, Iron-Deficiency; Clinical Trials as Topic; Diagnosis, Differential; Disaccharides; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron Deficiencies; Maltose; Prevalence; Thrombocytosis; Thromboembolism | 2013 |
Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Parenteral; Pregnancy; Pregnancy Complications, Hematologic | 2002 |
Clinical review of the newer intravenous iron therapy options.
Topics: Anemia, Iron-Deficiency; Clinical Protocols; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Renal Dialysis; Transferrin; Treatment Outcome | 2003 |
[Indications and practical management of parenteral iron therapy].
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Child; Erythrocyte Count; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Deficiencies; Male; Renal Dialysis; Sucrose; Time Factors; Transferrin | 2003 |
Parenteral iron therapy options.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex | 2004 |
Acute injury with intravenous iron and concerns regarding long-term safety.
Topics: Acute Kidney Injury; Anemia, Iron-Deficiency; Animals; Atherosclerosis; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammation; Infusions, Intravenous; Iron-Dextran Complex; Oxidative Stress; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Transferrin | 2006 |
Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Anemia, Iron-Deficiency; Animals; Endothelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammation; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Kidney Cortex; Kidney Tubules, Proximal; Lipid Peroxidation; Mitochondria; Oxidative Stress; Renal Dialysis; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha | 2006 |
[Administration of iron-containing drugs in non-dialyzed patients with chronic kidney disease].
Topics: Administration, Oral; Anemia, Iron-Deficiency; Diet, Protein-Restricted; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Iron Metabolism Disorders; Iron, Dietary; Kidney Failure, Chronic; Risk Factors; Sex Distribution; Treatment Outcome | 2007 |
The role of intravenous iron in anemia management and transfusion avoidance.
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Erythropoiesis; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous | 2008 |
The role of iron supplementation during epoietin treatment for cancer-related anemia.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Drug Administration Schedule; Erythropoiesis; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Iron, Dietary; Maltose; Neoplasms; Randomized Controlled Trials as Topic | 2009 |
Safety aspects of parenteral iron in patients with end-stage renal disease.
Topics: Anemia, Iron-Deficiency; Citric Acid; Drug Combinations; Drug Monitoring; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Compounds; Iron Overload; Iron-Dextran Complex; Kidney Failure, Chronic; Sorbitol | 1997 |
Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy.
Topics: Aged; Anemia, Iron-Deficiency; Anemia, Refractory; Animals; Calcitriol; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypophosphatemia; Iatrogenic Disease; Kidney Diseases; Male; Middle Aged; Osteomalacia; Phosphates | 1998 |
Parenteral iron use in the management of anemia in end-stage renal disease patients.
Topics: Anemia, Iron-Deficiency; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Peritoneal Dialysis; Recombinant Proteins; Renal Dialysis | 2000 |
53 trial(s) available for glucaric acid and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Heart; Hematinics; Humans; Kidney Failure, Chronic; Liver; Magnetic Resonance Imaging; Pancreas; Renal Dialysis | 2017 |
Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Pregnancy; Pregnancy Complications; Prospective Studies; Treatment Outcome | 2017 |
IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.
Topics: Aged; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2013 |
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
Topics: Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron; Male; Maltose; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2014 |
Responsiveness to parenteral iron therapy in children with oral iron-refractory iron-deficiency anemia.
Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Drug Resistance; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Male; Sucrose; Treatment Outcome | 2014 |
Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Infusions, Intravenous; Iron, Dietary; Puerperal Disorders; Severity of Illness Index; Spain; Treatment Outcome | 2014 |
A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
Topics: Aged; Anemia, Iron-Deficiency; Biomarkers; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Injections, Intravenous; Least-Squares Analysis; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2014 |
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Injections, Intravenous; Male; Middle Aged | 2014 |
Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.
Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Humans; Iron; Iron Deficiencies; Male; Pilot Projects; Renal Insufficiency, Chronic; Ventricular Function, Left | 2015 |
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Disaccharides; Early Intervention, Educational; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Maintenance Chemotherapy; Male; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Young Adult | 2015 |
A randomized trial of intravenous and oral iron in chronic kidney disease.
Topics: Administration, Intravenous; Administration, Oral; Aged; Anemia, Iron-Deficiency; Biomarkers; Disease Progression; Early Termination of Clinical Trials; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glomerular Filtration Rate; Glucaric Acid; Hematinics; Hemoglobins; Humans; Indiana; Kidney; Male; Middle Aged; Quality of Life; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2015 |
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Feces; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Gastrointestinal Microbiome; Glucaric Acid; Hematinics; Humans; Iron Deficiencies; Metabolome; Quality of Life; RNA, Ribosomal, 16S | 2017 |
Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; India; Maltose; Middle Aged; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2016 |
Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Hepcidins; Humans; Kidney Failure, Chronic; Maintenance Chemotherapy; Male; Renal Dialysis; Reticulocyte Count; Reticulocytes; Transferrin | 2016 |
A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Disaccharides; Drug Dosage Calculations; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Middle Aged; Time Factors; Treatment Outcome; Young Adult | 2017 |
The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
Topics: Adult; Age Factors; Analysis of Variance; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Probability; Renal Dialysis; Risk Assessment; Severity of Illness Index; Sex Factors; Treatment Outcome | 2008 |
Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Drug Administration Schedule; Drug Monitoring; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glomerular Filtration Rate; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Severity of Illness Index; Sucrose; Transferrin; Treatment Outcome | 2008 |
Iron prophylaxis in pregnancy: intravenous route versus oral route.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Trace Elements; Young Adult | 2009 |
Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment.
Topics: Adult; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Iron; Male; Prognosis; Prospective Studies; Recurrence; Treatment Outcome | 2009 |
Safety, therapeutic effectiveness, and cost of parenteral iron therapy.
Topics: Adult; Anemia, Iron-Deficiency; Costs and Cost Analysis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Male; Middle Aged | 2009 |
[Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study].
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Renal Dialysis | 2009 |
Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery.
Topics: Adult; Aged; Anemia, Iron-Deficiency; Blood Transfusion; Colorectal Neoplasms; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Transferrin; Treatment Outcome; Young Adult | 2009 |
Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; Cardiovascular Diseases; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hemoglobins; Humans; Kidney Diseases; Male; Maltose; Middle Aged; Risk Factors; Sucrose; Treatment Outcome | 2010 |
Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
Topics: Acetylcysteine; Adult; Anemia, Iron-Deficiency; Antioxidants; Biomarkers; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; India; Infusions, Intravenous; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Placebo Effect; Plethysmography; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome | 2010 |
Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial.
Topics: Adult; Aged; Albuminuria; Anemia, Iron-Deficiency; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Creatinine; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Diseases; Male; Middle Aged; Proteinuria | 2011 |
Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
Topics: Anemia; Anemia, Iron-Deficiency; C-Reactive Protein; Drug Administration Schedule; Drug Therapy, Combination; Erythrocyte Indices; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Interleukin-6; Pregnancy; Pregnancy Complications; Prospective Studies; Recombinant Proteins; Treatment Outcome | 2011 |
Do two intravenous iron sucrose preparations have the same efficacy?
Topics: Anemia, Iron-Deficiency; Cohort Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Prognosis; Renal Dialysis | 2011 |
FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Comorbidity; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Maltose; Middle Aged; Outcome Assessment, Health Care; Treatment Outcome; Young Adult | 2011 |
Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial.
Topics: Adult; Anemia, Iron-Deficiency; Dietary Supplements; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; India; Infusions, Intravenous; Iron, Dietary; Pregnancy; Pregnancy Complications; Young Adult | 2013 |
The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial.
Topics: Administration, Oral; Aged; Analysis of Variance; Anemia, Iron-Deficiency; Blood Transfusion; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chi-Square Distribution; Double-Blind Method; Elective Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Middle Aged; Spain; Sucrose; Tablets; Time Factors; Treatment Failure | 2012 |
Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Blood Loss, Surgical; Cesarean Section; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Postpartum Period; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Trimester, Third; Young Adult | 2013 |
Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Peritoneal Dialysis; Prospective Studies; Renal Insufficiency, Chronic; Young Adult | 2013 |
Iron deficiency anemia and levels of oxidative stress induced by treatment modality.
Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Antioxidants; Child; Child, Preschool; Developing Countries; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Glycine; Hemoglobinometry; Humans; Infant; Infusions, Intravenous; Injections, Intramuscular; Male; Oxidative Stress; Sucrose; Turkey | 2013 |
Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.
Topics: Anemia, Iron-Deficiency; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Population Surveillance; Treatment Outcome | 2003 |
A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding.
Topics: Adult; Aged; Aged, 80 and over; Anaphylaxis; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Tolerance; Edema; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Hemorrhage; Glucaric Acid; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Thrombophlebitis; Treatment Outcome; Urticaria | 2004 |
Parenteral iron therapy in treatment of anemia in end-stage renal disease patients: a comparative study between iron saccharate and gluconate.
Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Humans; Kidney Failure, Chronic; Male; Parenteral Nutrition; Renal Dialysis | 2005 |
Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Middle Aged; Nausea; Prospective Studies; Transferrin; Treatment Outcome | 2005 |
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
Topics: Adult; Anemia, Iron-Deficiency; Brachial Artery; Cardiovascular Diseases; Chelating Agents; Double-Blind Method; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Homocysteine; Humans; Iron; Male; Methionine; Nitroglycerin; Oxidative Stress; Razoxane; Regional Blood Flow; Risk Factors; Transferrin; Tyrosine; Vasodilation | 2006 |
Intravenous versus oral iron therapy for postpartum anaemia.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Prospective Studies; Puerperal Disorders | 2006 |
Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia.
Topics: Adult; Anemia, Iron-Deficiency; Double-Blind Method; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Humans; Prospective Studies; Research Design | 2007 |
[Intravenous treatment of postpartum anemia with trivalent ferrum preparation].
Topics: Anemia, Iron-Deficiency; Blood Cell Count; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Pregnancy; Puerperal Disorders; Sucrose | 2007 |
Optimum dosage regimen for iron sucrose.
Topics: Adult; Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Failure, Chronic; Male; Middle Aged; Treatment Outcome | 2007 |
Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial.
Topics: Anemia, Iron-Deficiency; Darbepoetin alfa; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Male; Middle Aged; Peritoneal Dialysis; Recombinant Proteins | 2006 |
Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammation Mediators; Infusions, Intravenous; Interleukin-6; Iron-Dextran Complex; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Serum Albumin; Tumor Necrosis Factor-alpha | 2007 |
Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Double-Blind Method; Exercise Tolerance; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Failure; Hematinics; Hospitalization; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Prospective Studies; Quality of Life; Renal Insufficiency, Chronic; Treatment Outcome | 2007 |
Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Reference Values; Sucrose; Time Factors | 1996 |
Iron supplementation in haemodialysis--practical clinical guidelines.
Topics: Anemia, Iron-Deficiency; Biomarkers; Drug Administration Routes; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Iron; Iron Deficiencies; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Support; Practice Guidelines as Topic; Prospective Studies; Recombinant Proteins; Renal Dialysis; Sucrose; Transferrin | 1998 |
Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin.
Topics: Adult; Anemia, Iron-Deficiency; C-Reactive Protein; Colitis, Ulcerative; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Glucocorticoids; Hemoglobins; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Recombinant Proteins; Reticulocyte Count; Treatment Outcome | 1999 |
Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial.
Topics: Anemia, Iron-Deficiency; Blood Pressure; Drug Hypersensitivity; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2000 |
Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.
Topics: Aged; Anemia, Iron-Deficiency; Epoetin Alfa; Erythrocyte Indices; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2001 |
Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy.
Topics: Anemia, Iron-Deficiency; Erythrocyte Count; Erythrocyte Indices; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Fetal Growth Retardation; Glucaric Acid; Hematocrit; Humans; Placental Insufficiency; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Recombinant Proteins; Reticulocyte Count; Transferrin; Treatment Outcome; Ultrasonography | 2001 |
Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.
Topics: Anemia, Iron-Deficiency; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammatory Bowel Diseases; Interleukin-6; Logistic Models; Male; Prospective Studies; Receptors, Transferrin; ROC Curve; Sensitivity and Specificity; Transferrin; Treatment Outcome | 2001 |
Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Birth Weight; Delivery, Obstetric; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infant, Newborn; Injections, Intravenous; Iron; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Sulfates | 2002 |
104 other study(ies) available for glucaric acid and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
Iron Sucrose and Blood Pressure Patterns During Hemodialysis.
Topics: Anemia, Iron-Deficiency; Blood Pressure; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Renal Dialysis | 2023 |
Intravenous iron for critically ill children. Comparison of three dose regimens.
Topics: Anemia; Anemia, Iron-Deficiency; Child; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Iron; Prospective Studies | 2024 |
Use of iron sucrose injection in anemia patients with reduced serum iron concentration during hospitalizations of digestive and liver diseases.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hospitalization; Humans; Iron; Liver Diseases | 2021 |
Intravenous Iron Sucrose for Children With Iron Deficiency Anemia.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infant; Iron; Male; Young Adult | 2017 |
Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK.
Topics: Anemia, Iron-Deficiency; Budgets; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron-Dextran Complex; Maltose; Retrospective Studies; United Kingdom | 2017 |
Iron sucrose: assessing the similarity between the originator drug and its intended copies.
Topics: Anemia, Iron-Deficiency; Biosimilar Pharmaceuticals; Chemical Phenomena; Chemistry, Pharmaceutical; Drug Approval; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Particle Size; Technology, Pharmaceutical; Therapeutic Equivalency | 2017 |
A robust and easily reproducible protocol for the determination of size and size distribution of iron sucrose using dynamic light scattering.
Topics: Anemia, Iron-Deficiency; Dynamic Light Scattering; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Light; Nanoparticles; Particle Size; Scattering, Radiation | 2018 |
Financial impact of intravenous iron treatments on the management of anaemia inpatients: a 1 year observational study.
Topics: Administration, Intravenous; Aged; Anemia, Iron-Deficiency; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inpatients; Length of Stay; Male; Maltose; Middle Aged; Retrospective Studies | 2018 |
A case study of an iron-deficient female Olympic 1500-m runner.
Topics: Adolescent; Anemia, Iron-Deficiency; Athletes; Athletic Performance; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Lactic Acid; Oxygen Consumption; Running; Sucrose; Young Adult | 2013 |
Iatrogenic osteomalacia: report of two cases.
Topics: Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gastrectomy; Glucaric Acid; Humans; Hypophosphatasia; Iatrogenic Disease; Male; Middle Aged; Osteomalacia; Postoperative Complications; Vitamin D Deficiency | 2013 |
Managing severe anemia when the patient is a Jehovah's Witness.
Topics: Adult; Anemia, Iron-Deficiency; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Fluid Therapy; Glucaric Acid; Hematinics; Humans; Jehovah's Witnesses; Male; Oxygen Inhalation Therapy; Recombinant Proteins; Severity of Illness Index; Vitamin B 12; Vitamin B Complex | 2013 |
Physicochemical and structural characterization of iron-sucrose formulations: a comparative study.
Topics: Anemia, Iron-Deficiency; Chromatography, Gel; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Magnetic Resonance Spectroscopy; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectroscopy, Fourier Transform Infrared; Sucrose | 2014 |
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey.
Topics: Anemia, Iron-Deficiency; Central Venous Catheters; Ferric Compounds; Ferric Oxide, Saccharated; France; Glucaric Acid; Humans; Infusions, Intravenous; Maltose; Neoplasms; Practice Patterns, Physicians'; Surveys and Questionnaires | 2013 |
Intravenous iron therapy in patients with heart failure. A double-edged sword.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Glucaric Acid; Heart Failure; Humans; Male | 2013 |
[Iron substitution in outpatients in Switzerland: Increase of costs associated with intravenous administration].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia, Iron-Deficiency; Child; Child, Preschool; Cost Savings; Cross-Sectional Studies; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobinometry; Humans; Infant; Infusions, Intravenous; Iron Compounds; Male; Maltose; Middle Aged; National Health Programs; Off-Label Use; Retrospective Studies; Switzerland; Young Adult | 2013 |
Iron therapy in patients with heart failure. A straight shot.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Glucaric Acid; Heart Failure; Humans; Male | 2013 |
Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data.
Topics: Anemia, Iron-Deficiency; Budgets; Cost Savings; Drug Substitution; Female; Ferric Compounds; Ferric Oxide, Saccharated; Financing, Personal; Glucaric Acid; Humans; Maltose; National Health Programs; Switzerland | 2014 |
Ferumoxytol: an intravenous iron, riskier than iron sucrose.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Clinical Trials as Topic; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans | 2013 |
Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD.
Topics: Anemia, Iron-Deficiency; Biological Availability; Cell Culture Techniques; Dose-Response Relationship, Drug; Drug Liberation; Drug Stability; Drugs, Generic; Enzyme-Linked Immunosorbent Assay; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hep G2 Cells; Humans; Injections, Intravenous; Macrophages; Spectrophotometry, Atomic; Sucrose | 2015 |
Successful treatment with 532-nm Q-switched Nd:YAG laser of cutaneous siderosis following intravenous iron extravasation.
Topics: Aged; Anemia, Iron-Deficiency; Extravasation of Diagnostic and Therapeutic Materials; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Lasers, Solid-State; Male; Skin Diseases; Sucrose | 2015 |
Rapid iron desensitization after generalized urticaria and facial angioedema.
Topics: Anemia, Iron-Deficiency; Angioedema; Desensitization, Immunologic; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Middle Aged; Sucrose; Urticaria | 2014 |
Intravenous iron sucrose for children with iron deficiency anemia: a single institution study.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infant; Male; Retrospective Studies | 2016 |
Chronic kidney disease: Serious adverse effects associated with IV iron in CKD.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Male; Renal Insufficiency, Chronic | 2015 |
Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.
Topics: Anemia, Iron-Deficiency; Cohort Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Time Factors | 2016 |
Oral or intravenous iron for anemia correction in chronic kidney disease?
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Male; Renal Insufficiency, Chronic | 2015 |
Potential of Alginate Encapsulated Ferric Saccharate Microemulsions to Ameliorate Iron Deficiency in Mice.
Topics: Alginates; Anemia, Iron-Deficiency; Animals; Biological Availability; Caco-2 Cells; Cells, Cultured; Emulsions; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Glucuronic Acid; Hexuronic Acids; Humans; Male; Mice | 2016 |
Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Dietary Supplements; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Parenteral; Male; Republic of Korea; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).
Topics: Acute Disease; Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Failure; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron-Dextran Complex; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome | 2016 |
Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells.
Topics: Anemia, Iron-Deficiency; Case-Control Studies; Cell Differentiation; Dendritic Cells; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Iron Compounds; Macrophages; Maltose; MicroRNAs; Monocytes; Phagocytosis | 2016 |
Correction of Iron Deficiency Anemia With Intravenous Iron Sucrose in Children With Inflammatory Bowel Disease.
Topics: Adolescent; Anemia, Iron-Deficiency; C-Reactive Protein; Child; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Gastrointestinal Agents; Glucaric Acid; Hemoglobins; Humans; Inflammatory Bowel Diseases; Infliximab; Injections, Intravenous; Iron; Male; Prospective Studies | 2016 |
Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study.
Topics: Administration, Intravenous; Adolescent; Anemia, Iron-Deficiency; Child; Crohn Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Male; Maltose; Portugal; Prospective Studies; Transferrin | 2017 |
Distinct in vitro Complement Activation by Various Intravenous Iron Preparations.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Complement Activation; Complement C1q; Complement C3d; Complement Membrane Attack Complex; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; In Vitro Techniques; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Mannose-Binding Lectin; Properdin; Renal Dialysis | 2017 |
Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infant; Infusions, Intravenous; Male; Prospective Studies; Treatment Outcome | 2008 |
Parenteral iron therapy.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Infusions, Parenteral; Iron; Patient Compliance | 2008 |
Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients.
Topics: Aged; Anemia, Iron-Deficiency; Centers for Medicare and Medicaid Services, U.S.; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; Risk Assessment; Time Factors; Treatment Outcome; United States | 2009 |
Use of iron sucrose in dialysis patients sensitive to iron dextran.
Topics: Adult; Aged; Anemia, Iron-Deficiency; Dialysis Solutions; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Humans; Iron-Dextran Complex; Male; Middle Aged; Renal Dialysis; Treatment Outcome; Young Adult | 2009 |
[Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients].
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Male; Middle Aged; Preoperative Care; Prospective Studies | 2009 |
Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Topics: Anemia, Iron-Deficiency; Drug-Related Side Effects and Adverse Reactions; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron-Dextran Complex; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Sucrose | 2009 |
Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; Blood Chemical Analysis; Bone Marrow; Bone Marrow Examination; Chi-Square Distribution; Chronic Disease; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron; Kidney Diseases; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Time Factors; Transferrin; Treatment Outcome; Young Adult | 2010 |
Letter 2: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128).
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Colorectal Neoplasms; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Postoperative Complications; Preoperative Care; Randomized Controlled Trials as Topic | 2010 |
Letter 1: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128).
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Colorectal Neoplasms; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Postoperative Complications; Randomized Controlled Trials as Topic | 2010 |
Iron replacement therapy: assessing today's options to prepare for bundling.
Topics: Anemia, Iron-Deficiency; Chemistry, Pharmaceutical; Dextrans; Drug Costs; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Medicare; Reimbursement Mechanisms; Renal Dialysis; Risk Adjustment; Safety; Sucrose; Treatment Outcome; United States | 2010 |
Eosinophilic fasciitis secondary to intravenous iron infusions.
Topics: Adult; Anemia, Iron-Deficiency; Eosinophilia; Fasciitis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous | 2010 |
Response to iron sucrose in dialysis patients sensitive to iron dextran.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron-Dextran Complex; Renal Dialysis | 2010 |
Influence of intravenous iron therapy on novel markers of iron deficiency.
Topics: Anemia, Iron-Deficiency; Biomarkers; Cross-Sectional Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Renal Dialysis; Reticulocytes; Time Factors; Transferrin; Treatment Outcome | 2010 |
Intravenous iron sucrose--an effective and attractive modality for perioperative anaemia management.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Preoperative Care | 2010 |
The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Health Care Costs; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Maltose; Middle Aged; Young Adult | 2010 |
Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Young Adult | 2011 |
Should intravenous iron be upfront therapy for iron deficiency anemia?
Topics: Anemia, Iron-Deficiency; Child; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Iron-Dextran Complex; Molecular Weight | 2011 |
Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy.
Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infant; Infusions, Intravenous; Male | 2011 |
IBD: Intravenous iron in IBD--what's the best preparation?
Topics: Anemia, Iron-Deficiency; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Maltose; Quality of Life; Treatment Outcome | 2011 |
Analysis of total and transferrin-bound iron in human serum for pharmacokinetic studies of iron-sucrose formulations.
Topics: Anemia, Iron-Deficiency; Colorimetry; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Reproducibility of Results; Spectrophotometry; Transferrin | 2011 |
Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator.
Topics: Adult; Anemia, Iron-Deficiency; Drugs, Generic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron, Dietary; Middle Aged; Therapeutic Equivalency; Young Adult | 2012 |
Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model.
Topics: Anemia, Iron-Deficiency; Animals; Disease Models, Animal; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Inflammation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2012 |
Management of iron deficiency anaemia in gynaecological patients at Jinnah Postgraduate Medical Centre, Karachi.
Topics: Academic Medical Centers; Adult; Anemia, Iron-Deficiency; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecologic Surgical Procedures; Hematinics; Humans; Pakistan; Preoperative Care; Recombinant Proteins; Reticulocyte Count; Time Factors; Treatment Outcome | 2011 |
Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Blood Transfusion; Cohort Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Maltose; Puerperal Disorders; Retrospective Studies; Treatment Outcome | 2012 |
Comparative rates of adverse events with different formulations of intravenous iron.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron-Dextran Complex; Male; Middle Aged; Multivariate Analysis; Retrospective Studies | 2012 |
Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide.
Topics: Absorptiometry, Photon; Adult; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hematinics; Humans; Osteomalacia; Phosphorus; Time Factors; Treatment Outcome; Withholding Treatment | 2012 |
An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic.
Topics: Administration, Intravenous; Ambulatory Care Facilities; Anemia, Iron-Deficiency; Clinical Protocols; Costs and Cost Analysis; Decision Support Techniques; Efficiency, Organizational; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hospitalization; Humans; Maltose; Patient Preference; Renal Insufficiency, Chronic; Transportation; United Kingdom | 2013 |
eComment. The problem of anaemia correction in cardiac surgery patients.
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Cardiac Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Male; Sucrose | 2012 |
Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients.
Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Confidence Intervals; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Medical Audit; Middle Aged; Obstetric Surgical Procedures; Postpartum Period; Pregnancy; Pregnancy Complications, Hematologic; Republic of Korea; Retrospective Studies | 2013 |
Uncommon adverse effect of a common medication.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypophosphatemia; Low Back Pain; Magnetic Resonance Imaging; Middle Aged; Osteomalacia; Pelvic Pain; Remission Induction; Treatment Outcome | 2013 |
Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Erythrocyte Indices; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infant; Infusions, Intravenous; Iron; Parenteral Nutrition; Reticulocyte Count; Time Factors | 2002 |
Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy.
Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gestational Age; Glucaric Acid; Hemoglobins; Humans; Injections, Intramuscular; Injections, Intravenous; Pregnancy; Pregnancy Complications; Prospective Studies; Treatment Outcome | 2002 |
Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
Topics: Anemia, Iron-Deficiency; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fluorescence; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Recombinant Proteins; Renal Dialysis; Reticulocyte Count; Reticulocytes | 2003 |
Intravenous iron therapy with saccharated iron oxide.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds | 1952 |
Iron therapy in pregnancy; a comparative study of various modes.
Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Iron; Pregnancy; Pregnancy Complications | 1954 |
Infusion of saccharated iron oxide in the treatment of iron deficiency anemia.
Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; North Carolina | 1962 |
[Use of venofer for iron deficiency correction in patients undergoing programmed hemodialysis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Sucrose; Treatment Outcome | 2003 |
Achieving optimal patient outcomes with intravenous iron.
Topics: Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Nurse-Patient Relations; Time Factors; Treatment Outcome | 2003 |
Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Peritoneal Dialysis | 2003 |
Treatment of iron deficiency anaemia with saccharated iron oxide given by the intravenous route.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron | 1951 |
[Intravenous ferric saccharate therapy of iron deficiency anemia in gynecology].
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecology; Humans; Iron | 1951 |
Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology.
Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecology; Humans; Iron; Obstetrics; Pregnancy | 1951 |
The hematologic response of the pregnant woman to intravenous saccharated iron oxide.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds; Pregnancy | 1952 |
Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products.
Topics: Anemia, Iron-Deficiency; Diarrhea; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypotension; Infusions, Intravenous; Male; Nausea; Prospective Studies; Renal Dialysis; Vomiting | 2004 |
[Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients].
Topics: Aged; Anemia, Iron-Deficiency; Ascorbic Acid; Biomarkers; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2004 |
[How to avoid a haemotransfusion which is not lifesaving? (our experience with administration of intravenous iron to pregnant women and young mothers)].
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Drug Administration Schedule; Erythrocyte Count; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gestational Age; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Sucrose | 2004 |
Intravenous iron in a primary-care clinic.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Renal Insufficiency; Sucrose | 2005 |
Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child.
Topics: Anemia, Iron-Deficiency; Chemical and Drug Induced Liver Injury; Child, Preschool; Deferoxamine; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Diseases; Glucaric Acid; Humans; Infusions, Intravenous; Liver Diseases; Male; Siderophores; Treatment Outcome | 2005 |
Parenteral iron therapy: a single institution's experience over a 5-year period.
Topics: Acetaminophen; Anemia, Iron-Deficiency; Diphenhydramine; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Hemorrhage; Glucaric Acid; Humans; Infusions, Parenteral; Iron Metabolism Disorders; Iron-Dextran Complex; Kidney Diseases; Male; Menorrhagia; Neoplasms; Premedication; Retrospective Studies; Telangiectasia, Hereditary Hemorrhagic; United States; von Willebrand Diseases | 2005 |
Anemia during pregnancy and in the postpartum: intravenous iron therapy revisited.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Pregnancy; Pregnancy Complications, Hematologic | 2005 |
Intravenous iron in the treatment of anemia of pregnancy. 1949.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; History, 20th Century; Humans; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Hematologic | 2005 |
Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients.
Topics: Aged; Anemia, Iron-Deficiency; Bacteremia; Chi-Square Distribution; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Poisson Distribution; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Statistics, Nonparametric | 2006 |
[Ferropenic anemia: some comments].
Topics: Anemia, Iron-Deficiency; Celiac Disease; Diagnosis, Differential; Ferric Compounds; Ferric Oxide, Saccharated; Folic Acid Deficiency; Glucaric Acid; Humans; Injections, Intravenous; Iron; Sucrose | 2006 |
Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex.
Topics: Adult; Anemia, Iron-Deficiency; Breast Feeding; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Iron; Iron Deficiencies; Milk, Human; Postpartum Period; Puerperal Disorders | 2007 |
[Treatments of the martial deficiencies: preparations available in France].
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; France; Glucaric Acid; Humans; Iron; Iron Deficiencies | 2006 |
Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.
Topics: Aged; Anemia, Iron-Deficiency; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hispanic or Latino; Humans; Infusions, Intravenous; Injections, Intravenous; Self Administration; Treatment Outcome | 2007 |
[Current recommendations for the treatment of iron deficiency anemia].
Topics: Anemia, Iron-Deficiency; Biomarkers; Drug Therapy, Combination; Epoetin Alfa; Erythrocyte Count; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications, Hematologic; Recombinant Proteins; Sucrose; Switzerland; Transferrin | 2007 |
The safety of intravenous iron sucrose use in the elderly patient.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Geriatrics; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2007 |
Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Postpartum Period; Pregnancy; Prevalence | 2005 |
Anemia and heart failure a new pathway?
Topics: Anemia, Iron-Deficiency; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Humans; Infusions, Intravenous; Natriuretic Peptide, Brain; Peptide Fragments; Treatment Outcome | 2007 |
Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia.
Topics: Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Male | 2008 |
A permanent tan from iron.
Topics: Aged; Anemia, Iron-Deficiency; Arm; Extravasation of Diagnostic and Therapeutic Materials; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hyperpigmentation | 2008 |
[Protective effect of the lysosomotrophic preparation rheopolyglucin in treating iron-deficient anemia with iron saccharate].
Topics: Anemia, Iron-Deficiency; Animals; Dextrans; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Intracellular Membranes; Kupffer Cells; Lysosomes; Microscopy, Electron; Rabbits | 1994 |
Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
Topics: Administration, Oral; Adult; Aged; Anemia; Anemia, Iron-Deficiency; Delayed-Action Preparations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Follow-Up Studies; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors | 1996 |
Effects of iron salts in sucrose on dental caries and plaque in rats.
Topics: Acids; Anemia, Iron-Deficiency; Animals; Crystallization; Dental Caries; Dental Plaque; Diet, Cariogenic; Dietary Sucrose; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Glycerophosphates; Hydrogen-Ion Concentration; Incidence; Prevalence; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Salivary Glands; Tooth Discoloration | 1997 |
[Parenteral iron replacement].
Topics: Administration, Oral; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Administration Schedule; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex | 1997 |
Intravenous iron (III) hydroxide-sucrose complex for anaemia in epidermolysis bullosa.
Topics: Anemia, Iron-Deficiency; Child; Epidermolysis Bullosa Dystrophica; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Recombinant Proteins; Sucrose | 1999 |
Improved response to erythropoietin therapy with long-term continuous iron supplementation.
Topics: Anemia, Iron-Deficiency; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Iron; Iron Overload; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis | 2000 |
Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia.
Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Pregnancy Outcome | 2000 |
[Iron deficiency. When parenteral substitution?].
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron | 2001 |
Iron sucrose or ferric gluconate?
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Renal Dialysis; Sucrose; Terminology as Topic | 2001 |
[Antipublic antibodies and pregnancy: use of iron sucrose in autologous blood donation with cryopreservation].
Topics: Adult; Anemia, Iron-Deficiency; Autoantibodies; Blood Preservation; Blood Transfusion, Autologous; Cryopreservation; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Injections, Intravenous; Iron; Pregnancy; Pregnancy Complications, Hematologic | 2002 |